We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
5 hedge funds and large institutions have $12M invested in Esperion Therapeutics in 2013 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WA
1
Wasatch Advisors
Salt Lake City,
Utah
| $5.93M | +$5.97M | +420,453 | New |
|
|
MCM
2
Mazama Capital Management
Portland,
Oregon
| $2.14M | +$2.15M | +151,622 | New |
|
3
Alyeska Investment Group
Chicago,
Illinois
| $2.04M | +$2.05M | +144,500 | New |
|
|
LCS
4
Levin Capital Strategies
New York
| $1.02M | +$1.02M | +72,133 | New |
|
|
WHI
5
William Harris Investors
Chicago,
Illinois
| $916K | +$923K | +65,000 | New |
|